{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T06:00:49Z","timestamp":1760853649291},"reference-count":39,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,29]],"date-time":"2014-11-29T00:00:00Z","timestamp":1417219200000},"content-version":"vor","delay-in-days":789,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1111\/j.1469-0691.2012.03973.x","type":"journal-article","created":{"date-parts":[[2012,7,5]],"date-time":"2012-07-05T06:20:15Z","timestamp":1341469215000},"page":"E389-E395","source":"Crossref","is-referenced-by-count":22,"title":["Antifungal therapy in European hospitals: data from the ESAC point-prevalence surveys 2008 and 2009"],"prefix":"10.1016","volume":"18","author":[{"given":"P.","family":"Zarb","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Amadeo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Muller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Drapier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Vankerckhoven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Davey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Goossens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/j.1469-0691.2012.03973.x_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1472-6904-5-1","article-title":"Hospital use of systemic antifungal drugs","volume":"5","author":"de With","year":"2005","journal-title":"BMC Clin Pharmacol"},{"key":"10.1111\/j.1469-0691.2012.03973.x_bib2","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1093\/jac\/dkm255","article-title":"Antifungal use in intensive care units","volume":"60","author":"Meyer","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2012.03973.x_bib3","doi-asserted-by":"crossref","first-page":"R5","DOI":"10.1186\/cc6766","article-title":"Impact of invasive fungal infection on outcomes of severe sepsis: a multicenter matched cohort study in critically ill surgical patients","volume":"12","author":"Xie","year":"2008","journal-title":"Crit Care"},{"key":"10.1111\/j.1469-0691.2012.03973.x_bib4","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/jac\/dkp251","article-title":"Incidence of candidaemia and relationship with fluconazole use in an intensive care unit","volume":"64","author":"Bassetti","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2012.03973.x_bib5","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1471-2334-6-80","article-title":"Candidaemia and antifungal therapy in a French University Hospital: rough trends over a decade and possible links","volume":"6","author":"Sendid","year":"2006","journal-title":"BMC Infect Dis"},{"key":"10.1111\/j.1469-0691.2012.03973.x_bib6","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1111\/j.1469-0691.2007.01812.x","article-title":"Changing pattern of candidaemia 2001\u20132006 and use of antifungal therapy at the University Hospital of Vienna, Austria","volume":"13","author":"Presterl","year":"2007","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/j.1469-0691.2012.03973.x_bib7","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.jhin.2007.04.018","article-title":"A point prevalence survey of hospital\u2010acquired infections and antimicrobial use in a paediatric hospital in north\u2010western Russia","volume":"66","author":"Hajdu","year":"2007","journal-title":"J Hosp Infect"},{"key":"10.1111\/j.1469-0691.2012.03973.x_bib8","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1016\/j.ijid.2009.03.013","article-title":"Inappropriate antimicrobial use in Turkish pediatric hospitals: a multicenter point prevalence survey","volume":"14","author":"Ceyhan","year":"2010","journal-title":"Int J Infect Dis"},{"key":"10.1111\/j.1469-0691.2012.03973.x_bib9","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1128\/JCM.00029-06","article-title":"Candidemia in Norway (1991 to 2003): results from a nationwide study","volume":"44","author":"Sandven","year":"2006","journal-title":"J Clin Microbiol"},{"issue":"Suppl 1","key":"10.1111\/j.1469-0691.2012.03973.x_bib10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ijantimicag.2006.03.006","article-title":"The changing epidemiology of invasive fungal infections: new threats","volume":"27","author":"Maschmeyer","year":"2006","journal-title":"Int J Antimicrob Agents"},{"key":"10.1111\/j.1469-0691.2012.03973.x_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3314\/jjmm.48.1","article-title":"Trends in the epidemiology of invasive fungal infections","volume":"48","author":"Warnock","year":"2007","journal-title":"Nihon Ishinkin Gakkai Zasshi"},{"key":"10.1111\/j.1469-0691.2012.03973.x_bib12","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1099\/jmm.0.46548-0","article-title":"Invasive fungal infections: a review of epidemiology and management options","volume":"55","author":"Enoch","year":"2006","journal-title":"J Med Microbiol"},{"key":"10.1111\/j.1469-0691.2012.03973.x_bib13","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s10096-004-1267-5","article-title":"Epidemiology and antifungal susceptibility ofCandida species isolated from blood: results of a 2\u2010year multicentre study in Spain","volume":"24","author":"Pem\u00e1n","year":"2005","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1111\/j.1469-0691.2012.03973.x_bib14","doi-asserted-by":"crossref","first-page":"985","DOI":"10.3201\/eid0908.030069","article-title":"Candidemia in Finland, 1995\u20131999","volume":"9","author":"Poikonen","year":"2003","journal-title":"Emerg Infect Dis"},{"key":"10.1111\/j.1469-0691.2012.03973.x_bib15","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.riam.2009.02.003","article-title":"Nosocomial candidemia at a general hospital: the change of epidemiological and clinical characteristics. A comparative study of 2 cohorts (1993\u20131998 versus 2002\u20132005)","volume":"26","author":"G\u00f3mez","year":"2009","journal-title":"Rev Iberoam Micol"},{"key":"10.1111\/j.1469-0691.2012.03973.x_bib16","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1469-0691.2008.01954.x","article-title":"Semi\u2010national surveillance of fungaemia in Denmark 2004\u20132006: increasing incidence of fungaemia and numbers of isolates with reduced azole susceptibility","volume":"14","author":"Arendrup","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/j.1469-0691.2012.03973.x_bib17","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1128\/JCM.02117-09","article-title":"Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5\u2010year analysis of susceptibilities ofCandida species to fluconazole and voriconazole as determined by CLSI standardized disk diffusion","volume":"48","author":"Pfaller","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2012.03973.x_bib18","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1080\/13693780802004996","article-title":"Seven\u2010year trend analysis of nosocomial candidemia and antifungal (fluconazole and caspofungin) use in Intensive Care Units at a Brazilian University Hospital","volume":"46","author":"Gir\u00e3o","year":"2008","journal-title":"Med Mycol"},{"key":"10.1111\/j.1469-0691.2012.03973.x_bib19","doi-asserted-by":"crossref","first-page":"979","DOI":"10.7326\/0003-4819-142-12_Part_1-200506210-00008","article-title":"Meta\u2010analysis: antibiotic prophylaxis reduces mortality in neutropenic patients","volume":"142","author":"Gafter\u2010Gvili","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1469-0691.2012.03973.x_bib20","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/TP.0b013e3182247bb4","article-title":"Universal prophylaxis with fluconazole for the prevention of early invasive fungal infection in low\u2010risk liver transplant recipients","volume":"92","author":"San\u2010Juan","year":"2011","journal-title":"Transplantation"},{"key":"10.1111\/j.1469-0691.2012.03973.x_bib21","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.clinthera.2009.05.011","article-title":"Cost\u2010effectiveness analysis of micafungin versus fluconazole for prophylaxis of invasive fungal infections in patients undergoing hematopoietic stem cell transplantation in Korea","volume":"31","author":"Sohn","year":"2009","journal-title":"Clin Ther"},{"key":"10.1111\/j.1469-0691.2012.03973.x_bib22","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.clinthera.2008.04.020","article-title":"Cost\u2010effectiveness analysis of antifungal prophylaxis in patients undergoing hematopoietic stem cell transplantation","volume":"30","author":"Schonfeld","year":"2008","journal-title":"Clin Ther"},{"key":"10.1111\/j.1469-0691.2012.03973.x_bib23","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1439-0507.2010.01961.x","article-title":"Antifungal treatment strategies in patients with haematological diseases or cancer: from prophylaxis to empirical, pre\u2010emptive and targeted therapy","volume":"55","author":"Mikolajewska","year":"2012","journal-title":"Mycoses"},{"issue":"Suppl 1","key":"10.1111\/j.1469-0691.2012.03973.x_bib24","doi-asserted-by":"crossref","first-page":"i25","DOI":"10.1093\/jac\/dkq439","article-title":"Systematic review and mixed treatment comparison of randomized evidence for empirical, pre\u2010emptive and directed treatment strategies for invasive mould disease","volume":"66","author":"Freemantle","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2012.03973.x_bib25","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/QCO.0b013e32832e074d","article-title":"Prevention and treatment of invasive fungal diseases in neutropenic patients","volume":"22","author":"Almyroudis","year":"2009","journal-title":"Curr Opin Infect Dis"},{"key":"10.1111\/j.1469-0691.2012.03973.x_bib26","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1093\/jac\/dkq430","article-title":"Identification of targets for quality improvement in antimicrobial prescribing: the web\u2010based ESAC Point Prevalence Survey 2009","volume":"66","author":"Zarb","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2012.03973.x_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10408410903241444","article-title":"Epidemiology of invasive mycoses in North America","volume":"36","author":"Pfaller","year":"2010","journal-title":"Crit Rev Microbiol"},{"key":"10.1111\/j.1469-0691.2012.03973.x_bib28","doi-asserted-by":"crossref","first-page":"83","DOI":"10.7326\/0003-4819-149-2-200807150-00004","article-title":"Empirical fluconazole versus placebo for intensive care unit patients: a randomized trial","volume":"149","author":"Schuster","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1469-0691.2012.03973.x_bib29","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1097\/CCM.0b013e31819dec9b","article-title":"Evolving role of early antifungals in the adult intensive care unit","volume":"37","author":"Lam","year":"2009","journal-title":"Crit Care Med"},{"key":"10.1111\/j.1469-0691.2012.03973.x_bib30","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s10096-008-0666-4","article-title":"Risk\u2010based fluconazole prophylaxis ofCandida bloodstream infection in a medical intensive care unit","volume":"28","author":"Faiz","year":"2009","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1111\/j.1469-0691.2012.03973.x_bib31","doi-asserted-by":"crossref","first-page":"287","DOI":"10.47102\/annals-acadmedsg.V40N6p287","article-title":"Selection of resistant fungi in liver transplant recipients during use of newer antifungal agents \u2013 a report of two cases","volume":"40","author":"Lingegowda","year":"2011","journal-title":"Ann Acad Med Singapore"},{"key":"10.1111\/j.1469-0691.2012.03973.x_bib32","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/jac\/dkq023","article-title":"European Surveillance of Antimicrobial Consumption (ESAC): outpatient systemic antimycotic and antifungal use in Europe","volume":"65","author":"Adriaenssens","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2012.03973.x_bib33","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/1471-2334-10-150","article-title":"Inappropriate empiric antifungal therapy for candidemia in the ICU and hospital resource utilization: a retrospective cohort study","volume":"10","author":"Zilberberg","year":"2010","journal-title":"BMC Infect Dis"},{"key":"10.1111\/j.1469-0691.2012.03973.x_bib34","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3904\/kjim.2009.24.3.263","article-title":"Blood stream infections byCandida glabrata andCandida krusei: a single\u2010center experience","volume":"24","author":"Choi","year":"2009","journal-title":"Korean J Intern Med"},{"key":"10.1111\/j.1469-0691.2012.03973.x_bib35","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jinf.2007.10.014","article-title":"Increasing incidence ofCandida parapsilosis candidemia with caspofungin usage","volume":"56","author":"Forrest","year":"2008","journal-title":"J Infect"},{"key":"10.1111\/j.1469-0691.2012.03973.x_bib36","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1517\/14656566.6.15.2617","article-title":"Pharmacoeconomics of antifungal pharmacotherapy \u2013 challenges and future directions","volume":"6","author":"Johnson","year":"2005","journal-title":"Expert Opin Pharmacother"},{"issue":"Suppl 3","key":"10.1111\/j.1469-0691.2012.03973.x_bib37","doi-asserted-by":"crossref","first-page":"S318","DOI":"10.1093\/clinids\/12.Supplement_3.S318","article-title":"Pharmacokinetics and tissue penetration of fluconazole in humans","volume":"12","author":"Brammer","year":"1990","journal-title":"Rev Infect Dis"},{"issue":"Suppl 1","key":"10.1111\/j.1469-0691.2012.03973.x_bib38","doi-asserted-by":"crossref","first-page":"i5","DOI":"10.1093\/jac\/dki218","article-title":"Changing patterns and trends in systemic fungal infections","volume":"56","author":"Richardson","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2012.03973.x_bib39","author":"European Centre for Disease Prevention and Control"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14610788?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14610788?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,24]],"date-time":"2023-06-24T02:12:34Z","timestamp":1687572754000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X14610788"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":39,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S1198743X14610788"],"URL":"https:\/\/doi.org\/10.1111\/j.1469-0691.2012.03973.x","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}